New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis.

Biomedicines · 2023 · PMC9953090 · PMID 36830772

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

However, a positive trend for efficacy was seen in the treatment group, particularly after 60 days, highlighting the promising role in the future of omalizumab in IA.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.